C4 Therapeutics prices $182 million IPO
LONDON: RTW Venture Fund Limited notes the announcement by its portfolio company C4 Therapeutics on 01 October 2020 of its pricing of a $182.4 million...
Andrew Hirsch named Chief Executive Officer of C4 Therapeutics
WATERTOWN: C4 Therapeutics (C4T), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins through degradation, announced the hiring of...